A novel non-invasive diagnostic marker for arterial erectile dysfunction: cavernosal artery ondulation index measured in the flaccid phase
The Journal of Sexual Medicine · 09.04.2026 · 23 (5)
DOI: 10.1093/jsxmed/qdag090 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 09.04.2026. Verfasst von Göksel Tuzcu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Aydın Adnan Menderes University, Faculty of Medicine, Aydın, Turkey. Hauptthemen laut MEDLINE: Penis, Impotence, Vasculogenic, Erectile Dysfunction. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Arteriogenic insufficiency (AI) is the most common vascular cause of erectile dysfunction (ED) and is traditionally diagnosed using semi-invasive papaverine-induced penile Doppler ultrasonography (P-PDUS).
Aim
To evaluate the feasibility and diagnostic accuracy of the cavernosal artery ondulation index (CA-OI) measured during the flaccid penile phase for identifying AI in men with ED.
Methods
This prospective study included 90 men with clinically confirmed ED (International Index of Erectile Function-5 ≤ 25) and suspected vascular etiology. Gray-scale and color Doppler ultrasonography were performed in the flaccid state to measure CA-OI. AI was diagnosed according to established P-PDUS criteria, and patients were classified into AI (n = 28) and non-AI (n = 62) groups. CA-OI values were compared between groups, and receiver operating characteristic curve analysis was used to evaluate diagnostic performance. Outcomes The primary outcome was the diagnostic accuracy of flaccid-phase CA-OI for detecting AI.
Results
Patients with AI were significantly older than those without AI (59.8 ± 8.8 vs. 46.4 ± 13.5 years, P < .001) and had a higher prevalence of diabetes mellitus (P < .001). Mean CA-OI values were significantly higher in the AI group (2.76 ± 0.28 vs. 2.33 ± 0.17, P < .001). Receiver operating characteristic analysis demonstrated excellent diagnostic performance, with an area under the curve of 0.906. A CA-OI cut-off value of 2.46 yielded 89.3% sensitivity and 79% specificity for identifying AI. Clinical Implications Measurement of CA-OI in the flaccid phase offers a non-invasive and clinically practical approach for the initial screening of arteriogenic ED, potentially reducing the need for intracavernosal injection. Strengths and Limitations The principal strength of this study is the first evaluation of CA-OI as a non-invasive diagnostic marker obtained during the flaccid penile phase; limitations include the single-center design and the use of P-PDUS rather than angiography as the reference standard.
Conclusion
CA-OI measured during the flaccid penile phase is a highly accurate, non-invasive marker for AI in men with ED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Aydın Adnan Menderes University, Faculty of Medicine, Aydın, Turkey.
- Department of Urology, Aydın Adnan Menderes University, Faculty of Medicine, Aydın, Turkey.
ORCID-Profile: Göksel Tuzcu, Erhan Ateş, Ali Alkaşi, Aral Varol, Çağatay Özsoy, Mustafa Gök
Zitieren
APA
Tuzcu, G., Ateş, E., Alkaşi, A., Varol, A., Özsoy, Ç., & Gök, M. (2026). A novel non-invasive diagnostic marker for arterial erectile dysfunction: cavernosal artery ondulation index measured in the flaccid phase. The Journal of Sexual Medicine, 23(5). https://doi.org/10.1093/jsxmed/qdag090
Vancouver
Tuzcu G, Ateş E, Alkaşi A, Varol A, Özsoy Ç, Gök M. A novel non-invasive diagnostic marker for arterial erectile dysfunction: cavernosal artery ondulation index measured in the flaccid phase. The Journal of Sexual Medicine. 2026;23(5). doi:10.1093/jsxmed/qdag090
BibTeX
@article{Tuzcu2026,
author = {Tuzcu, Göksel and Ateş, Erhan and Alkaşi, Ali and Varol, Aral and Özsoy, Çağatay and Gök, Mustafa},
title = {A novel non-invasive diagnostic marker for arterial erectile dysfunction: cavernosal artery ondulation index measured in the flaccid phase},
journal = {The Journal of Sexual Medicine},
year = {2026},
volume = {23},
number = {5},
doi = {10.1093/jsxmed/qdag090}
}
EUVIMED